monthly healthcare review october 2016 - · pdf filemonthly healthcare review october 2016...

Monthly Healthcare Review

October 2016

Company NameLast Financing

DateHQ Location Description

Last

Financing

Size

(Millions)

Lead Manager

Myovant Sciences

(MYOV) 26-Oct-16 Brisbane, CA Provider of bio-pharmaceutical products and therapies for women's health diseases. 217.50

Barclays Capital,

Citigroup Global

Markets, Cowen and

Company

ConvaTec (CTEC) 26-Oct-16

Greensboro,

NC

Manufacturer of products for ostomy care, wound care and skin care. Its products include

bathing, moisturizing and conditioning products, skin cleansers, skin protectants and

antifungal products for colostomy, ileostomy and urostomy surgeries. 1972.63

Bank of America,

Goldman Sachs

Group, UBS Group

Ra Pharmaceuticals

(RARX) 25-Oct-16 Cambridge, MA Developer of drugs based on intracellular protein-protein interactions. 91.64

BMO Capital

Markets, Credity

Suisse Securities,

Jefferies

iRhythm Technologies

(IRTC) 20-Oct-16

San Francisco,

CA

Provider of a platform and device for long-term continuous cardiac monitoring that enables

diagnosis earlier in the clinical pathway. 107.00

J.P. Morgan

Securities, Morgan

Stanlet & Co.

CRISPR Therapeutics

(CRSP) 19-Oct-16

Basel,

Switzerland Developer of genome-editing technology for patients with serious diseases. 91.00

Barclays Capital,

Citigroup Global

Markets, Piper

Jaffray & Co.

shop-apotheke.com

(SAE) 13-Oct-16

Venlo,

Netherlands

Retailer of pharmaceuticals and health products online. The company provides prescription

processing, mail order prescription and drugs for cold and flu, hay fever, diabetes and other

diseases. 100.00

Citi, Berenber,

Commerzbank

FRISQ Holding

(FRISQ) 12-Oct-16

Stockholm,

Sweden

The company is engaged in the research, production and sale of healthcare communication

software and other digital communication services. Undisclosed Undisclosed

InDex Pharmaceuticals

(INDEX) 11-Oct-16

Stockholm,

Sweden

Developer of RNA blocking drugs as well as diagnostic and prognostic tools for the medical

industry. 29.29 Undisclosed

The following table includes the medical devices, biotechnology, pharmaceuticals, and healthcare IPO pricings, filings and withdrawals announced over the previous month.

IPOs

Compiled by: Morgan Reape

Source: Pitchbook 1


October 2016

Company NameLast Financing

DateHQ Location Description

Last

Financing

Size

(Millions)

Lead Manager

The following table includes the medical devices, biotechnology, pharmaceuticals, and healthcare IPO pricings, filings and withdrawals announced over the previous month.

IPOs

Obalon (OBLN) 6-Oct-16 Carlsbad, CA

Developer of a non-surgical, reversible weight-loss option that entails a deflated gastric

balloon that is swallowed and then inflated in the user's stomach. 75.00

Canaccord Genuity,

Stifel Nicolaus &

Company, UBS

Investment Bank


Source: Pitchbook 2


October 2016

Company Name

Last

Financing

Date

HQ Location Round Description

Last

Financing

Size

(Millions)

Lead Investor(s)

Silicon Therapeutics 31-Oct-16 Boston, MA Angel Operator of a computational drug research and development company. 6.25 Undisclosed

Cricket Health 31-Oct-16 San Francisco, CA Seed Round

Provider of software and services for customers suffering from chronic

kidney diseases including home dialysis services and a peer mentorship

program. 2.63 First Round Capital

CoheroHealth 31-Oct-16 New York, NY Early Stage VC

Developer of a healthcare device platform that enables respiratory patients

to use a mobile device to monitor health and coordination between

patients and their care providers. 10.81 Undisclosed

Chronix Biomedical 31-Oct-16 San Jose, CA Later Stage VC

Developer of diagnostic test kits that are used for the detection and

monitoring of various stages of chronic diseases in human beings and

animals. 5.01 Undisclosed

Bridge Medicines 31-Oct-16 New York, NY Early Stage VC

The company focuses on therapeutics development and works with

participating scientists to establish and fund biopharmaceutical companies

responsible for managing individual projects and advancing them to clinical

trials. Undisclosed

Bay City Capital,

Deerfield

Management

Avizia 31-Oct-16 Reston, VA Early Stage VC

Developer of a telehealth and remote conferencing software platform,

workflow management software, store-and-forward capabilities with

electronic health record integration, and a line of peripherals, such as

digital stethoscopes and examination cameras. 17.00

HealthQuest

Capital

Alcresta Therapeutics 31-Oct-16 Newton, MA Later Stage VC

Developer of enzyme-based nutritional products that help in breaking

down complex foods to manage disease for infants, older adults and

patients battling acute or chronic conditions. 50.89

Athyrium Capital

Management

Promethera Biosciences 28-Oct-16

Mont-Saint-Guibert,

Belgium Later Stage VC

Developer of cell therapy products using allogenic progenitor cells

harvested from healthy human livers. 11.20

Vesalius Biocapital,

SMS Investments,

Fund+

2C Tech Corporation 28-Oct-16 Irvine, CA

PE Growth/

Expansion

Developer of medical devices based on nanotechnology for the treatment

of back of the eye diseases. 4.00

Mantucket Capital,

other undisclosed

Private Equity Placements and Venture Capital RoundsThe following table includes institutionally placed private equity financings for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced

over the previous month.


Source: Pitchbook 3


October 2016

Company Name

Last

Financing

Date


Last

Financing

Size

(Millions)

Lead Investor(s)



Unity Biotechnology 27-Oct-16 San Francisco, CA Early Stage VC

Provider of therapeutics designed to prevent, halt or reverse diseases

associated with aging, including osteoarthritis, glaucoma, heart disease and

kidney failure. 116.00

ARCH Venture

Partners, Venrock,

Mayo Clinic

Ventures

Oxford Genetics 27-Oct-16

Oxford, United

Kingdom Early Stage VC

Developer of DNA, protein, virus and cell line technologies for

mammalian expression and bio-production. 1.32

Mercia

Technologies

Lab7 Systems 27-Oct-16 Austin, TX Angel

Provider of a scientific workflow management software platform for rapid

detection and diagnosis of genetic diseases. 3.00 Undisclosed

Kiyatec 27-Oct-16 Greenville, SC Later Stage VC

Developer of technologies for the pharmaceutical, biomedical and life

science industries. 3.15

Upstate Carolina

Angel Network,

other undisclosed

Inositec 27-Oct-16 Zurich, Switzerland Seed Round

Owner and operator of a biotechnology research company. The company

focuses on the development of life-saving small molecule drugs based on

inositol phosphate, a natural facilitator of diverse cellular functions. 1.44

VI Partners,

Zürcher

Kantonalbank

Infina Connect

Healthcare Systems 27-Oct-16 Cary, NC Angel

Provider of electronic referral management, coordination of care and EHR

interoperability. 0.10 Undisclosed

Gemstone

Biotherapeutics 27-Oct-16 Baltimore, MD Angel

Developer of methods for advanced wound healing and tissue

vascularization. The company's technologies include stem cell engineering

methodologies and biomaterial-based inventions that can be utilized in

therapeutic and research applications. 0.70 Undisclosed

FC Laboratories 27-Oct-16 Moscow, Russia Early Stage VC

Developer of drugs that can be used for the treatment and prevention of

solid clots in blood vessels. 0.17 Primer Capital

Ciel Medical 27-Oct-16 Redwood City, CA Angel

Developer of a medical device to treat ventilator associated pneumonia, a

technology to improve the treatment of kidney stones, and a device to

enhance the protection of patients in intensive care units. 1.39

Astia, other

undisclosed

BrainCheck 27-Oct-16 Houston, TX Seed Round

Developer of a health assessment and management application connecting

patients and their care teams in both the concussion and dementia markets. 3.00 Undisclosed


Source: Pitchbook 4


October 2016

Company Name

Last

Financing

Date


Last

Financing

Size

(Millions)

Lead Investor(s)



QR Pharma 26-Oct-16 Berwyn, PA Angel Developer of drugs for the treatment of neuro-degenerative disorders. 0.80 Undisclosed

Helix Opco 26-Oct-16 San Carlos, CA Early Stage VC

Provider of a consumer-facing human genome platform that will sequence,

store and analyze individuals' genetic data and provide a marketplace of

services through various partners, allowing people to explore their

geneology or understand their risk for inherited disease. Undisclosed

Kleiner Perkins

Caufield & Byers

Genomics Medicine

Ireland 26-Oct-16 Dublin, Ireland Early Stage VC

Developer of a disease-specific database of population genomics. The

company is developing a scientific platform to examine the human genome

in order to better understand the role of genetics in disease and rare

conditions, and to lead to new prevention strategies and treatments. 40.00

ARCH Venture

Partners, Polaris

Partners, GV

Doctify 26-Oct-16

London, United


Developer of an online platform that allows users to compare doctors

using verified patient reviews and filter for distance, availability and insurer

to find the right doctor. Undisclosed

Amadeus Capial

Partners

Bonesupport 26-Oct-16 Lund, Sweden Later Stage VC

Developer of injectable, osteoconductive biomaterials for the treatment of

fragility fractures caused by osteoporosis, as well as bone voids due to

trauma, benign tumors, disease or surgical procedures. 37.00 Tellacq

Allele Biotech 26-Oct-16 San Diego, CA Later Stage VC

Developer of novel technologies and products for biomedical researchers.

The company explores the mechanisms of biological processes to increase

accessibility to molecular biology research tools by providing customer

service in addition to the technical knowledge to facilitate their use. 11.00 Undisclosed

Protosthetics 25-Oct-16 Barnesville, MN Angel

Manufacturer and distributor of prosthetic devices utilizing additive

manufacturing (3D printing). 0.36 Undisclosed

Jivana Biotechnology 25-Oct-16 Oak Park, IL Angel

Developer of therapeutics for liver, breast, prostate, NSCLC, ovarian,

thyroid, melanoma, and neuro and glioblastoma cancers. 1.00 Undisclosed

Iproteos 25-Oct-16 Barcelona, Spain Early Stage VC

Developer of next generation drugs for the treatment of schizophrenia,

epilepsy and pediatric cancer. 1.68 Caiza Capital Risc


Source: Pitchbook 5


October 2016

Company Name

Last

Financing

Date


Last

Financing

Size

(Millions)

Lead Investor(s)



Cirina 25-Oct-16 San Francisco, CA Angel

Developer of blood-plasma testing products that enables doctors to detect

and monitor life threatening diseases in their patients at their early stages. 12.00 Min Cui

ACO Partner 25-Oct-16 Phoenix, AZ Early Stage VC Provider of value-based care delivery and reimbursement services. Undisclosed

Trinnovate

Ventures

Signum Surgical 24-Oct-16 Galway, Ireland Early Stage VC

Developer of an implant to prevent infection and encourage healing in

perianal fistula, a colorectal condition. 1.65

Western

Development

Commission, Halo

Business Angel

Network,

Glanzmann

Enterprises, Chip

Hance, other

undisclosed

Primal Therapies 24-Oct-16 Boise, ID Angel Producer of oral health tablets. 0.68 Undisclosed

NovioSense 24-Oct-16

Nijmegen,

Netherlands Early Stage VC

Developer of a wireless non-invasive sensor that measures glucose levels

continuously in tear fluid and aims to produce a needle-free service for

continuous glucose monitoring. Undisclosed

Health Innovations,

Topfunds

Gelderland,

Fraunhofer

Ventures

LindaCare 24-Oct-16 Brussels, Belgium Early Stage VC

Developer of a single, integrated software platform for chronic disease

management, patient tele-monitoring and patient safety. 0.50

Connecticut

Innovations

Kalibratev 24-Oct-16

Altamonte Springs,

FL Angel

Developer of a personal vitamin monitoring device that calibrates vitamin

dosages from blood sample tests. 0.15 Undisclosed

Healthians 24-Oct-16 Gurgaon, India Early Stage VC

Provider of an online preventive healthcare platform that serves as an

aggregator of diagnostic labs, crowdsourced sample collectors, clinics,

hospitals and pharmacies. It builds individual health profiles of users,

assigns them a personal health score, recommends health checks and keeps

track of their health. 3.00 Beenext


Source: Pitchbook 6


October 2016

Company Name

Last

Financing

Date


Last

Financing

Size

(Millions)

Lead Investor(s)



Eaze 24-Oct-16 San Francisco, CA Early Stage VC

Developer of an on-demand healthcare application that allows patients to

access medical marijuana by automating patient verification and caregiver

dispatch via any connected device. 13.00 Fresh VC

Axial Healthcare 24-Oct-16 Nashville, TN Early Stage VC

Developer of software for healthcare providers to assess the effectiveness

of their pain-management plans. 17.04 Oak HC/FT

Anutra Medical 24-Oct-16 Morrisville, NC Early Stage VC Developer of a local anesthetic delivery system for dentistry. 2.33 Undisclosed

AlayaCare 24-Oct-16 Toronto, Canada Early Stage VC

Developer of an outcome-focused software platform that connects

healthcare providers with thier patients helping them with efficient

scheduling, mobile capture of clinical documentation, remote patient

monitoring and virtual care. Undisclosed

Desjardins Capital

régional et

coopératif, Bob

Gainey, other

undisclosed

Neurovation Labs 21-Oct-16 New York, NY Seed Round

Owner and operator of a biotechnology company focused on diagnosing

and treating anxiety disorders, especially post-traumatic stress disorders. 0.15 Undisclosed

DermTech 21-Oct-16 La Jolla, CA Later Stage VC

Developer of molecular tests to identify, diagnose and analyze melanoma,

prostate cancer, psoriasis and various skin disorders. 2.07 Undisclosed

Concentric Analgesics 21-Oct-16 San Francisco, CA Early Stage VC Developer of therapeutics for the management of postoperative pain. 6.60 Undisclosed

Rheon Medical 20-Oct-16

Lausanne,

Switzerland Later Stage VC

Producer of adjustable glaucoma drainage devices that provides physicians

with the control over the patients' post-operative intra-ocular pressure. Undisclosed

BlueOcean

Ventures

Propeller Health 20-Oct-16 Madison, WI Later Stage VC

Provider of a mobile health service for asthma and chronic obstructive

pulmonary disease. The company uses a combination of smartphone

applications and snap-on inhaler sensors that track when and how often

patients use their inhaled medications. 21.50

3M Ventures, S.R.

One, Hikma

Ventures

HyHelp 20-Oct-16 Frankfurt, Germany Seed Round

Developer of a mobile device that enables hospitals and other healthcare

institutions to track and monitor hand hygiene events and indications of

doctors and nurses. Undisclosed

Think Health

GmbH, other

undisclosed


Source: Pitchbook 7


October 2016

Company Name

Last

Financing

Date


Last

Financing

Size

(Millions)

Lead Investor(s)



Emulate 20-Oct-16 Boston, MA Early Stage VC

Developer of a platform for mimicking human physiology so that

responses to medicines, chemicals and diseases can be predicted. It also

offers a range of applications in drug development, personalized medicine,

agriculture and chemical-based consumer products. 45.00

Hansjörg Wyss,

NanoDimension,

Cedars Sinai Health

System

Cardiogram 20-Oct-16 San Francisco, CA Seed Round Provider of an application for measuring heart rate. 2.00

Andreessen

Horowitz

Blackthorn Therapeutics 20-Oct-16

South San

Francisco, CA Early Stage VC

Developer of therapeutic drugs for the treatment of brain and other

neurological disorders. 40.00

ARCH Venture

Partners

Zygood 19-Oct-16 Dayton, MD Angel

Developer and marketer of medical devices to cure pain. The company's

device offers a drug-free palliative care for bad backs, nerve pain from

chemotherapy and arthritic joint pain. 0.19 Undisclosed

YGEIA Group 19-Oct-16 Dallas, TX Angel

Owner and operator of a healthcare advisory firm. The company

specializes in providing actionable patient level data for a personalized

treatment plan to reduce hospital re-admissions. 0.03 Undisclosed

Vicarious Surgical 19-Oct-16 Cambridge, MA Early Stage VC

Developer of a virtual reality software integrated with surgical robotics for

use in minimally invasive surgical procedures. 4.19

Rothenberg

Ventures, Chandler

Wang, other

undisclosed

iCellate Medical 19-Oct-16 Stockholm, Sweden Angel

Developer of products in the field of cancer research and detection. The

company's instrument uses bio-mechanical characteristics to capture the

circulating tumor cells from the blood. 1.76 Undisclosed

Bigfoot Biomedical 19-Oct-16 Milpitas, CA Early Stage VC

Developer of a Type 1 diabetes management system for people with

insulin-dependent diabetes and blood sugar control. 35.50

Quadrant Capital

Advisors

4G Clinical 19-Oct-16 Boston, MA Early Stage VC

Provider of a trial supply management platform focused on facilitating the

work of assigning patients to treatment groups, managing clinical supply,

and dispensing medicines used in clinical trials. 5.00 Schooner Capital


Source: Pitchbook 8


October 2016

Company Name

Last

Financing

Date


Last

Financing

Size

(Millions)

Lead Investor(s)



True North

Therapeutics 18-Oct-16 San Francisco, CA Later Stage VC

Developer of humanized antibodies for development into novel drugs to

treat rare diseases in hematology, transplantation, and dermatology. 45.00

HBM Healthcare

Investments,

Redmile Group,

Perceptive

Advisors

Science 37 18-Oct-16 Culver City, CA Early Stage VC

Developer of networked patient-centric models for clinical research to

rapidly accelerate biomedical discovery. 31.00

Redmile Group,

Lux Capital, dRx

Capital

SafetyCulture 18-Oct-16

Townsville,

Australia Later Stage VC

Provider of safety-auditing software. The company's cloud-based platform

enables companies to store all of their safety-compliance documents in one

place and to instantly download them in a customizable format. 22.73 Index Ventures

Mio Global 18-Oct-16 Vancouver, Canada Later Stage VC Developer and seller of heart rate monitoring wristbands and watches. 15.00 Hydra Ventures

Health Copilot 18-Oct-16

Cammeray,

Australia

Accelerator/

Incubator

Developer of a virtual health and wellness platform that uses artificial

intelligence to send real-time messages that instruct the amount of physical

activity needed to lose weight. 0.01 Monash Incubate

Eywa Pharma 18-Oct-16 Chennai, India

PE Growth/

Expansion Developer of generic medicines and drugs. 30.00

Eight Roads

Ventures, F-Prime

Capital Partners,

Envestor Ventures,

other undisclosed

EnXray 18-Oct-16

Liverpool, United


Developer, producer and distributor of equipment for in-house X-ray

sterilization of medical supplies. 1.05

The North West

Fund

Connexion Point 18-Oct-16 Salt Lake City, UT

PE Growth/

Expansion

Provider of a healthcare plan intelligence platform helping healthcare

providers communicate with members and prospects about plans, benefits

and options. Undisclosed

VSS Structured

Capital


Source: Pitchbook 9


October 2016

Company Name

Last

Financing

Date


Last

Financing

Size

(Millions)

Lead Investor(s)



ADC Therapeutics 18-Oct-16

Epalinges,

Switzerland Early Stage VC

Developer of antibody and non-antibody drug conjugate products that

target hematological cancers and tumor cells. 105.00

Auven

Therapeutics, Wild

Family Office,

AstraZeneca

Veritas Genetics 17-Oct-16 Danvers, MA Early Stage VC

Provider of genetic testing services. The company's proprietary technology

can detect a wider range of variations in a gene than are typically found in

next generation sequencing and offers a screening test for hereditary breast

and ovarian cancer risk. 30.00

TrustBridge

Partners, Jiangsu

Simcere

Pharmaceutical

TrakCel 17-Oct-16

Cardiff, United


Provider of cell therapy process management and supply chain integration

technology to meet data management, reporting and analysis needs of

clinical trials. Undisclosed

Telegraph Hill

Partners

Providence Medical

Technology 17-Oct-16 Walnut Creek, CA Later Stage VC

The company offers a minimally invasive platform of differentiated

cervical implants and instruments to treat cervical degenerative disc disease

through indirect decompression and fusion. 3.69 Undisclosed

Kayentis 17-Oct-16

Gif-sur-Yvette,

France Later Stage VC

Operator of a clinical data collection and medical data management

company that provides services in the fields of pharmaceutical activities,

clinical trial management and sales force management. 3.90 Innovation Capital

Health Chain Solutions 17-Oct-16 Cincinnati, OH Angel

Provider of a comprehensive set of tools for healthcare providers by

adopting IoT digital healthcare software, enabling patients and providers to

measure the quality of care. Its software platform also offers healthcare

consultancy services. 0.08 Undisclosed

Catalytic DS 17-Oct-16 Wilton, CT Later Stage VC

Developer of a digital work space for medical researchers. The company

offers a cloud-based platform that enables researchers to access data,

analytics, visualizations and collaborative tools. 6.00 Undisclosed

Castle Creek

Pharmaceuticals 17-Oct-16 Bedminster, NJ Early Stage VC Developer of drugs for rare diseases in the neurology sector. 48.00

Fidelity

Management &

Research, other

undisclosed

CancerGene Connect 17-Oct-16 Dallas, TX Angel

Provider of a cloud-based genetic counseling system that includes a

collection of family medical history and cancer risk assessment. 0.30 Undisclosed


Source: Pitchbook 10


October 2016

Company Name

Last

Financing

Date


Last

Financing

Size

(Millions)

Lead Investor(s)



Brainomix 17-Oct-16

Oxford, United

Kingdom Later Stage VC

Developer of software to improve stroke diagnosis that automatically

interprets the brain computed tomography scans of patients. 1.97

Parkwalk Advisors,

Chimera Partners

American Aerogel 17-Oct-16 Rochester, NY Later Stage VC

Developer of various thermal insulation applications to transport

biomedical, pharmaceutical and other temperature sensitive products. 1.25 Undisclosed

PennAlt Organics 14-Oct-16 Pittsburgh, PA Early Stage VC Provider of treatment for disorders related to the brain, spine and nerves. 6.00 iNetworks Advisors

Ovia Health 14-Oct-16 Boston, MA Early Stage VC

Provider of a digital healthcare platform for women and families. The

company provides a suite of mobile applications for fertility, pregnancy

and parenting. 10.00

Martin Ventures,

Zaffre Investments

TransThera Bioscience 13-Oct-16 Nanjing, China Early Stage VC

Developer of novel chemical entity drugs that covers disease areas such as

oncology, cardiovascular diseases and other therapeutic areas. 10.00

Morningside

Ventures

Sidero Bioscience 13-Oct-16 Hershey, PA Angel Provider of medical food for iron deficiency management. 0.14 Undisclosed

Seamless Medical

Systems 13-Oct-16 Santa Fe, NM Early Stage VC Provider of a cloud-based patient engagement platform. 4.56 Undisclosed

Patara Pharma 13-Oct-16 San Diego, CA Early Stage VC

Developer of therapies for the treatment of allergic and inflammatory

diseases. 6.00 Undisclosed

NantCell 13-Oct-16 Culver City, CA Angel

Developer of immunology-based treatments and drugs for the treatment of

cancer and auto-immune diseases. 4.25 Undisclosed

EDGe Surgical 13-Oct-16 Chicago, IL Angel Manufacturer of medical devices for orthopedic surgeries. 0.85 Undisclosed

Convergent Dental 13-Oct-16 Natick, MA Later Stage VC

Developer of a computer-guided tooth preparation system. The company

is a dental equipment and technology company and developer of Solea, a

computer-aided, CO2 laser system for both hard and soft tissue

indications. 27.74

Long River

Ventures

Causeway Sensors 13-Oct-16

Belfast, United


Developer of biosensors for the identification of low levels of protein

within the human body. 0.66 Kernel Capital

Pinscriptive 12-Oct-16

San Juan

Capistrano, CA Seed Round

Developer of a big data analytics platform to identify the clinically effective

specialty medications at an optimal cost for individual patients. 1.09

Frost Data Capital,

other undisclosed




October 2016

Company Name

Last

Financing

Date


Last

Financing

Size

(Millions)

Lead Investor(s)



Matrix Analytics 12-Oct-16 Denver, CO Angel

Provider of an online software tool to detect, assess, and manage the

treatment of pulmonary nodules and lung cancer. 0.74 Undisclosed

Jiseki Health 12-Oct-16 Palo Alto, CA Seed Round

Provider and developer of a healthcare coordination platform that offers

service delivery to its patients in terms of hospital-provided clinical care

and supportive community health resources. 1.21 PivotNorth Capital

iScribes 12-Oct-16 Durham, NC Angel Provider of virtual medical scribe services. 0.70 Undisclosed

Geneticure 12-Oct-16 Minnetonka, MN Angel

Developer of genetic tests that help doctors and clinicians create

personalized and patient-specific treatments for controlling high blood

pressure and hypertension. 0.25 Undisclosed

Fortimedix 12-Oct-16 Nuth, Netherlands Later Stage VC Developer and manufacturer of coronary and peripheral stents. 12.32 Chemelot Ventures

Cruzar Medsystems 12-Oct-16 Braintree, MA Early Stage VC

Developer of medical technology and devices. The company is designing a

catheter that allows physicians to cross obstructive lesions without capital

equipment. 2.85 Undisclosed

Cianna Medical 12-Oct-16 Aliso Viejo, CA Later Stage VC

Manufacturer of medical devices for the treatment of early stage breast

cancer in women. The company offers a surgical guidance system that uses

real time audible and visual indicators to target tissue during lumpectomy

and excisional biopsy procedures. 4.25 Undisclosed

Braintrain 20:20 12-Oct-16

Sheffield, United

Kingdom Seed Round Provider and manufacturer of sleep aid technology-based products. Undisclosed

Merica

Technologies

Akriveia Therapeutics 12-Oct-16 Skillman, NJ Early Stage VC

Provider of immunotherapy treatments for cancer. The company provides

a platform designed to address issues with immunotherapies by restricting

the action of the therapeutic agent to just the site of the cancer. 7.50

F-Prime Capital

Partners

Titan Spine 11-Oct-16 Mequon, WI

PE Growth/

Expansion

Designer and manufacturer of titanium interbody cage devices utilized in

the spinal-fusion surgical process. 7.70

Southlake Equity

Group

Symbiotic Health 11-Oct-16

Port Washington,

NY Early Stage VC

Developer of an oral capsule therapeutic that cures Clostridium Difficile

diarrhea by repopulating the patient with a protective microbiome. 0.85 Undisclosed




October 2016

Company Name

Last

Financing

Date


Last

Financing

Size

(Millions)

Lead Investor(s)



Relievant Medsystems 11-Oct-16 Redwood City, CA Later Stage VC

Developer of a therapy that uses radio-frequency energy delivered through

a small access tube into the vertebral body to ablate basivertebral nerve. 36.00

New Enterprise

Associates

Crystalplex 11-Oct-16 Pittsburgh, PA Later Stage VC

Provider of nanotechnology to the biomedical research and medical

diagnostic markets. 2.15 Undisclosed

CaroGen 11-Oct-16 Farmington, CT Early Stage VC

Developer of nanoparticle therapeutic vaccine immunotherapies designed

to engage the body's immune system to both recognize and fight off

infectious diseases and cancer. 2.08 Undisclosed

Azitra 11-Oct-16 Farmington, CT

Accelerator/

Incubator

Developer of a microbiome-based therapeutics system using sophisticated

molecular, genetic and microbiological techniques to treat skin diseases. 0.35 Breakout Labs

OncoResponse 10-Oct-16 Houston, TX Early Stage VC Developer of therapeutic antibodies against immuno-oncology targets. 19.50

ARCH Venture

Partners, Canaan

Partners, MD

Anderson

Medmonk 10-Oct-16 Milpitas, CA Angel

Operator of a technology platform for pharmaceutical companies that

helps pharmacists obtain funding for patients who cannot afford their

medical expenses. 0.15

Mohit Goelm,

Sudip

Bandopadhyay

Intelligent Medical

Objects 10-Oct-16 Northbrook, IL

PE Growth/

Expansion

Provider of medical terminology content and services supporting clinical

workflow. The company's products allow physicians to easily find and

enter medical terminology at the point of care with an EHR system using

solutions built on IMO's proprietary content of over 800,000 clinical

concepts and mapping to five million terms across more than 100 code

sets. Undisclosed Warbug Pincus

Evidation Health 10-Oct-16 San Mateo, CA Early Stage VC

Provider of a data analysis platform for the healthcare sector. The

company helps its partners quantify and optimize health outcomes through

advanced analytics of medical, behavioral and contextual data at the patient-

consumer level. 15.00 B Capital Group

Benchling 9-Oct-16 San Francisco, CA Early Stage VC

Provider of an electronic lab collaboration and analysis suite for the

pharmaceutical industry. 7.00 Thrive Capital




October 2016

Company Name

Last

Financing

Date


Last

Financing

Size

(Millions)

Lead Investor(s)



SurgiQ 8-Oct-16 Genoa, Italy Early Stage VC

Provider of a health-tech multi-modal platform for managing patients in

hospitals. 0.24 Wolsey Ventures

Synaptive 7-Oct-16 Toronto, Canada Early Stage VC

Provider of advanced tools and information for neurosurgeons,

radiologists, surgeons and hospitals to focus on patient outcomes. 4.64 Undisclosed

Prescription Advisory

Systems & Technology 7-Oct-16 Jenkintown, PA Early Stage VC

Developer of an application for multi-source data integration and

synthesis, audibility and institutional oversight to protect patients,

physicians and healthcare institutions. 1.78

Ben Franklin

Technology

Partners of

Southeastern

Pennsylvania, other

undisclosed

Nascent Surgical 7-Oct-16 Eden Prairie, MN Angel

Developer of a surgical smoke evacuator to capture and remove

bioaerosols and surgical plumes formed at the incision site during open

surgery. 0.19 Undisclosed

Cordex Systems 7-Oct-16 Annapolis, MD Later Stage VC

Manufacturer of a medical device for detecting and monitoring

cardiovascular disease by measuring endothelial dysfunction. 0.73 Undisclosed

YProTech 6-Oct-16

Alderley Edge,

United Kingdom

PE Growth/

Expansion

Provider of chemistry services, including contract synthesis, process

optimization, manufacture of chemical libraries and materials

characterization. Undisclosed

Catapult Ventures

Group

MUJO Mechanics 6-Oct-16

Nottingham, United

Kingdom Angel

Manufacturer of joint fitness equipments. The company uses patented

devices and cloud software for a data-driven approach to musculoskeletal

healthcare. 1.93 Undisclosed

MSI Methylation

Sciences 6-Oct-16 Burnaby, Canada Later Stage VC

Developer of a small molecule therapy for adjunctive treatment of major

depressive disorder. 30.00 Quark Venture

LifeMine Therapeutics 6-Oct-16 Cambridge, MA Early Stage VC

Owner and operator of a biotechnology company. The company produces

drugs optimized through fungal biosphere and deploys the molecules for

the treatment of intractable human diseases via novel biological

mechanisms. 5.00 Undisclosed

Kurin 6-Oct-16 San Diego, CA Angel

Provider of a software platform that offers healthcare service providers

guidelines to manage wastage and risk associated with hospitality

procedures. 2.32 Undisclosed




October 2016

Company Name

Last

Financing

Date


Last

Financing

Size

(Millions)

Lead Investor(s)



Cliniconex 6-Oct-16 Kanata, Canada Seed Round

Provider of a cloud-based platform to healthcare providers that automates

patient outreach services, such as booking notifications, reminders,

cancellations, surveys and preventative-care reminders. Undisclosed

Capital Angel

Network, Wesley

Clover

STAT-Diagnostica &

Innovation 5-Oct-16 Barcelona, Spain Later Stage VC

Provider of portable multi-analyte instruments for molecular and immuno-

assay testing for different clinical settings. Undisclosed

Glide Healthcare

Partners

Skincure Oncology 5-Oct-16 Chicago, IL Angel

Provider of a skin cancer treatment device used without anesthesia and

post-treatment reconstructive surgeries. 1.10 Undisclosed

Garwood Medical

Devices 5-Oct-16 Buffalo, NY Angel

Developer of medical devices to treat implant infections, stimulate bone

growth and aid wound healing using electro stimulation. It also offers

consulting services relating to electronic powered medical device product

design in the field of telemetry. 3.60 Undisclosed

Enable Injections 5-Oct-16 Cincinnati, OH Later Stage VC

Developer of disposable body-worn devices that allows patients self-

administration of viscosity drugs for the treatment of cancer, autoimmune

diseases, genetic and rare diseases. 30.00 ORI Capital

Aspyrian Therapeutics 5-Oct-16 San Diego, CA Early Stage VC Developer of cancer-targeted therapies. 55.20

Hiroshi Mikitani,

other undisclosed

Achilles Therapeutics 5-Oct-16

London, United


Developer of patient-specific therapies to target truncal neo-antigens and

protein markers unique to each individual that harness the immune system

to destroy cancer cells. 17.36 Syncona Partners

Zeitgeist Health SE 4-Oct-16 Stuttgart, Germany

Accelerator/

Incubator Developer of a web application for obstetrics and gynecology purposes. 0.02 Startupbootcamp

UE LifeSciences 4-Oct-16 Philadelphia, PA Early Stage VC Provider of non-invasive breast cancer detection devices. 1.20

Kiran Mazumdar-

Shaw

Turner Innovations 4-Oct-16 Orem, UT

Accelerator/

Incubator Manufacturer of x-ray imaging systems. Undisclosed

Utah Science

Technology and

Research Initiative

Theraworx 4-Oct-16 Asheville, NC Later Stage VC

Provider of therapeutic skin care products. The company manufactures

products that include specialty care packs for peri-care prior to foley

catheter insertion and on-going foley maintenance. 24.41 Undisclosed

Secure Medication

Systems 4-Oct-16

Greenwood Village,

CO Angel Developer of locking prescription vials. Undisclosed Undisclosed




October 2016

Company Name

Last

Financing

Date


Last

Financing

Size

(Millions)

Lead Investor(s)



Satchel Health 4-Oct-16 Nashville, TN Seed Round

Provider of a software platform that connects patients in a nursing home

or skilled nursing facility to remote care. 1.00 NueCura Partners

Nanolive 4-Oct-16

Ecublens,

Switzerland Early Stage VC Developer of a microscope for 3D imaging of living cells. 0.51 Swisscom Ventures

MediLad 4-Oct-16 Berlin, Germany

Accelerator/

Incubator

Developer of a patient engagement and virtual health management

application that provides expertise about women's health and sexually

transmitted diseases through its messaging platform. 0.02 Startupbootcamp

Inflammatory Response

Research 4-Oct-16 Santa Barbara, CA Angel Provider of drug development services for inflammatory disorders. 0.02 Undisclosed

Healx 4-Oct-16

Cambridge, United


Provider of a technology platform that allows the user to match potential

treatments to rare conditions and patients. It uses advanced data analytics,

including machine learning and computational biology techniques,

alongside scientific literature analysis. 1.97

Amadeus Capital

Partners, Jonathan

Milner

Genprex 4-Oct-16 Austin, TX Later Stage VC Developer of targeted molecular therapies for cancer. 0.95 Undisclosed

Eccrine Systems 4-Oct-16 Cincinnati, OH Early Stage VC

Developer of small disposable electronic patches that use sensors to

measure different chemicals present in sweat. 5.50 CincyTech

Dermtest 4-Oct-16 Tallinn, Estonia

Accelerator/

Incubator

Provider of telemedicine services that combines a digital dermoscope and a

specialist diagnosis medical expert for the early detection of skin cancer. 0.02 Startupbootcamp

Coronect 4-Oct-16 Wildau, Germany

Accelerator/

Incubator

Provider of a medical device for storing diagnosed data in a cloud

platform. 0.02 Startupbootcamp

Complion 4-Oct-16 Cleveland, OH Early Stage VC

Provider of a platform for creating and maintaining clinical-trial regulatory

documentation in a binder interface to search for information, a format

designed to save hospitals time and money. 2.90 Undisclosed

Seniorlink 3-Oct-16 Boston, MA

PE Growth/

Expansion

Provider of professional advice, education, in-home geriatric care

assessments and ongoing care management for elders and individuals with

disabilities while also offering a platform to connect caregivers with the

users. 10.00

NewSpring Capital,

other undisclosed

Recursion

Pharmaceuticals 3-Oct-16 Salt Lake City, UT Early Stage VC

The company uses a drug-screening platform to reposition drugs to treat

rare genetic diseases. 48.98 Lux Capital




October 2016

Company Name

Last

Financing

Date


Last

Financing

Size

(Millions)

Lead Investor(s)



Navage 3-Oct-16

Brooklyn Heights,

OH Angel

Manufacturer of a handheld nasal irrigator that uses controlled suction to

wash the nasal passages. 0.03 Undisclosed

Moxe Health 3-Oct-16 Madison, WI Early Stage VC Developer of electronic medical record and data integration technology. 5.50

Safeguard

Scientifics

MD Revolution 3-Oct-16 San Diego, CA Early Stage VC

Developer of digital health technology to predict, prevent and reverse

chronic diseases. 9.74 Undisclosed

Jump Technologies 3-Oct-16 Eagan, MN

PE Growth/

Expansion

Developer of cloud-based supply and inventory management software and

related services to healthcare providers, office supply, food logistics,

transportation companies and distributors. 1.00 Undisclosed

I-Vitae 3-Oct-16 Brescia, Italy

Accelerator/

Incubator

Developer of a diagnostic screening biomarker to detect temporary

infertility in women. 0.02 Startupbootcamp

FindAir 3-Oct-16 Kraków, Poland

Accelerator/

Incubator

Developer of a medical inhaler that tracks geo-location-based data that can

help to prevent an asthma episode and monitor a patient's medication

dosage. 0.02 Startupbootcamp

Clarify Health Solutions 3-Oct-16 San Francisco, CA Early Stage VC

Provider of a collaborative healthcare platform that enables patients and

their families to understand the different steps of treatment and recovery

and share the patient's recovery data with doctors and clinicians. 4.93 Undisclosed

Chiron Health 3-Oct-16 Austin, TX Early Stage VC

Developer of a web-based telemedicine platform for outpatient follow-up

care. 4.79 Undisclosed

Carrick Therapeutics 3-Oct-16 Dublin, Ireland Early Stage VC Developer of cancer therapeutics. 95.00

ARCH Venture

Partners, Woodford

Investment

Management

CancerAid 3-Oct-16

Camperdown,

Australia Seed Round

Developer of an application that provides cancer patients and their

caregivers with accurate information specific to their illness and treatment

plan, a digital journal, a database for their medical records and access to a

global community of people fighting the disease, as well as information and

news stories from clinicians, researchers and charities. 0.95

Clinton Capital

Partners




October 2016

Company Name

Last

Financing

Date


Last

Financing

Size

(Millions)

Lead Investor(s)



BrainShake 3-Oct-16 Vantaa, Finland Early Stage VC

Provider of a blood testing device which can be used to detect metabolic

biomarkers for chronic diseases. 2.24

Cor Group, other

undisclosed

CareSync 1-Oct-16 Tampa, FL Later Stage VC

Provider of a platform that collects, organizes and stores health

information. 4.20

Tullis Health

Investors,

Greycroft Partners

C4 Imaging 1-Oct-16 Bellaire, TX Angel

Provider of medical devices that enable clinicians to perform image-guided

procedures. 1.10 Undisclosed




October 2016

Acquirer Target HQ Location Date DescriptionTransaction

Value (Millions)

Invekra

Oculus (Latin

America Business) Mexico 31-Oct-16

Manufacturer of microcyn-based products. The business manufactures

dermatology, surgical, wound care and animal healthcare products. 19.5

Novogen Glioblast Sydney, Australia 31-Oct-16 Owner and operator of an oncology-focused biotechnology company. 2.54

ProMedic Life Sciences

Telesta

Therapeutics

Saint-Laurent,

Canada 28-Oct-16

The company provides licensing, acquisition and development of transformational

therapeutics for the treatment of serious human diseases, such as cancer, immune

diseases, and targeted rare diseases. 32.38

MCH Private Equity Hc Clover Madrid, Spain 28-Oct-16

Provider of soft gelatin capsules manufactured from the collagen of animal skin or

bone. Undisclosed

Vocera

Communications Extension Fort Wayne, IN 28-Oct-16

Provider of an enterprise alarm safety and event response platform that allows

tracking of real-time patient events using context-driven notifications. 55.00

Zimmer Biomet

Holdings Respondwell Grand Rapids, MI 27-Oct-16

Provider of a tele-rehabilitation technology. The company offers a software

platform that enables physical therapists to create a personalized rehab program

while using a sensor to track patient performance. Undisclosed

Molex Phillips-Medisize Hudson, WI 26-Oct-16

Manufacturer of medical products, such as disposable insulin pens, glucose

meters, specialty inhalation drug delivery devices, single use surgical devices and

consumable diagnostic components. Undisclosed

Biogroup Astralab Limoges, France 26-Oct-16

Provider of testing and consulting services in domains such as parasitology,

immunology, molecular biology, blood analysis, allergen sensitivities and related

assessments. Undisclosed

Allergan

Vitae

Pharmaceuticals

Fort Washington,

PA 25-Oct-16

Operator of a clinical-stage biopharmaceutical company focused on the discovery

of drugs for diseases, including treatments for psoriasis, autoimmune diseases and

atopic dermatitis. 639.00

Horizon Pharma

Raptor

Pharmaceuticals Novato, CA 25-Oct-16

Provider of biopharmaceutical therapies to treat diseases that are debilitating and

life-threatening, such as Huntington's disease, non-fatty liver disease and primary

liver cancer. 800.00

BioCardia Tiger X Medical Los Angeles, CA 24-Oct-16

Developer of reconstructive joint devices and spinal surgical devices to eliminate

joint pain. Undisclosed

Thuasne Group

Orthotic

Composites

London, United

Kingdom 21-Oct-16 Manufacturer of orthopedic braces. Undisclosed

Sunovion

Pharmaceuticals Cynapsus Toronto, Canada 21-Oct-16 Operator of a specialty central nervous system pharmaceutical company. 624.00

Mergers and AcquisitionsThe following table includes mergers and acquisitions for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced over the previous

month.




October 2016


Value (Millions)


month.

Allscripts Careport Health Boston, MA 20-Oct-16

Provider of a web-based platform enabling hospitals, patients and post-hospital

care providers to coordinate and manage care across the post-acute care

continuum. Undisclosed

TrendShift

Health Data

Intelligence Columbus, OH 19-Oct-16

Developer of a SaaS-based application for healthcare analytics with a focus on

population health management, risk adjustment and stratification services. Undisclosed

ISTO Technologies

Arteriocyte Medical

Systems Hopkinton, MA 19-Oct-16

Manufacturer of medical devices to improve patient outcomes in cardiac,

orthopedic and vascular surgeries. Undisclosed

Essentium Materials TriFusion Devices College Station, TX 14-Oct-16 Producer of prosthetic limbs using 3D printing technology. Undisclosed

Shoppers Drug Mart QHR Technologies Kelowna, Canada 13-Oct-16 Developer of medical records technology software. 129.84

Rubery Owen

Merlin Powder

Characterisation

Loughborough,

United Kingdom 13-Oct-16

Provider of pharmaceutical product testing and analysis devices. The company

specializes in compaction testing of pharmaceutical powders using a hydraulic

compaction simulator that can be used to determine fundamental powder

properties and can also be set up to simulate commercial production conditions to

establish viability of new products at early phases of development. Undisclosed

PierianDx Tute Genomics Provo, UT 12-Oct-16

Provider of a cloud-based genetics application designed to analyze and annotate

entire human genomes, helping physicians develop personalized medicines. Undisclosed

Oxford Immunotec

Global Immunetics Boston, MA 12-Oct-16

Developer of assay technology for infectious disease diagnosis and pathogen

detection. 12.00

Cambrex

Cambrex High

Point High Point, NC 7-Oct-16

Provider of chemistry services to pharmaceutical and biotechnology companies

focusing on the commercial development of small molecule drugs. 25.00

Sprint Healthcare Aseptika

Huntingdon, United

Kingdom 6-Oct-16

Provider of integrated systems that can be used by consumers and their healthcare

service providers to manage long-term health conditions through self-monitoring.

Its products are device agnostic, incorporating sensors and monitors ranging from

consumer accessories to in vitro diagnostics with a focus on respiratory disease. Undisclosed




October 2016


Value (Millions)


month.

Unisurge International

Pennine Healthcare

(UK and Ireland

Procedure Pack

Business) 5-Oct-16 Manufacturer of medical devices and custom procedure packs. Undisclosed

Mayoly Spindler Kibion Uppsala, Sweden 5-Oct-16

Supplier of breath tests for the diagnosis of the stomach ulcer bacterium

Helicobacter pylori. Undisclosed

Clayton, Dubilier &

Rice

Medical Data

Exchange Long Beach, CA 4-Oct-16

Provider of electronic medical record charting systems, billing automation and

information processing systems, medical groups and individual physicians. Undisclosed

Evolent Health Valence Health Chicago, IL 3-Oct-16

Provider of a clinical integration solution that includes assistance with physician

integration strategies, data collection and analysis, performance reporting and

point-of-care tools. 219.40

Ecolab UltraClenz Jupiter, FL 3-Oct-16

Manufacturer of hand hygiene compliance monitoring systems including sanitizer

dispensers, patient safeguard systems, touch-free soap and door monitoring

systems. Undisclosed

Nolato Treff

Degersheim,

Switzerland 3-Oct-16

Manufacturer of self-care diagnostics products such as syringes, cell culture tanks

and specimen containers. 48.97

Linden Capital Partners ProPharma Group Overland Park, KS 3-Oct-16

Provider of medical information, pharmacovigilance and compliance consulting

services including quality assurance, pharmacovigilance, process validation,

corporate compliance and ethics, medical information, and computer systems

validation. Undisclosed

Probi USA Nutraceutix Redmond, WA 3-Oct-16

Manufacturer of probiotic powders, probiotics and nutraceuticals in capsules and

tablets. 105.00

Medical Transcription

Billing MediGain Plano, TX 3-Oct-16

Provider of billing and reimbursement services, revenue cycle management,

physician credentialing, denials management, medical coding and billing audits. 7.00

Laboratory Corporation

of America

Clearpath

Diagnostics Syracuse, NY 3-Oct-16

Provider of anatomic pathology and diagnostic services for various tissue

specimen. Undisclosed

LINET

BORCAD (Medical

Division)

Fryčovice, Czech

Republic 3-Oct-16 Manufacturer of birthing beds, gynecological chairs and other related products. Undisclosed




October 2016


Value (Millions)


month.

Teva Pharmaceutical

Indistries Anda Parsippany, NJ 3-Oct-16

Distributor of generic, brand and specialty pharmaceutical products, vaccines,

injectables and medicines to independent pharmacies, pharmacy chains, alternate

care providers such as hospitals, nursing homes and mail order pharmacies. 500.00

Inovalon

Creehan &

Company Canonsburg, PA 1-Oct-16

The company provides technology management and hosting, commercial

software, consulting and operational support services for specialty pharmacies,

biotech pharmaceutical manufacturers and other healthcare organizations. 130.00

BrainCool BeneChill San Diego, CA 1-Oct-16

Developer of a non-invasive cooling technology used to increase survival rates

after acute ischemic events, such as cardiac arrest, stroke and traumatic brain

injury. 2.23



monthly healthcare review october 2016 - · pdf filemonthly healthcare review october 2016...

Documents